🚨 $CYTK
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $61.3800 per common share. (Date: 2026-10-06)
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $61.3800 per common share. (Date: 2026-10-06)
SEC Filing: CYTK
Click to view the official SEC document.
www.sec.gov
October 6, 2026 at 8:36 PM
🚨 $CYTK
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $61.3800 per common share. (Date: 2026-10-06)
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $61.3800 per common share. (Date: 2026-10-06)
🔴 #CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $61.38
Total: $215K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 3,500 shares @ $61.38
Total: $215K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
FormDelta — Insider Trading Alerts
Malik Fady Ibraham just sold $215K in CYTK. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
October 6, 2026 at 8:30 PM
🔴 #CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $61.38
Total: $215K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 3,500 shares @ $61.38
Total: $215K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
What the November 14 PDUFA is for, and why the nHCM filing matters more:
Cytokinetics (#$CYTK): What Is the November 14 PDUFA Date Actually For?
Catalysts + risks: www.merlintrader.com/cytokinetics...
Cytokinetics (#$CYTK): What Is the November 14 PDUFA Date Actually For?
Catalysts + risks: www.merlintrader.com/cytokinetics...
October 4, 2026 at 8:01 PM
What the November 14 PDUFA is for, and why the nHCM filing matters more:
Cytokinetics (#$CYTK): What Is the November 14 PDUFA Date Actually For?
Catalysts + risks: www.merlintrader.com/cytokinetics...
Cytokinetics (#$CYTK): What Is the November 14 PDUFA Date Actually For?
Catalysts + risks: www.merlintrader.com/cytokinetics...
Insider selling
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.1M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.1M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
CYTK: CYTOKINETICS INC (CIK 0001061983) | Earnings Feed
CIK 0001061983 — CYTOKINETICS INC SEC filings: 10-K, 10-Q, 8-K reports & Form 4 insider trades. Free EDGAR access.
earningsfeed.com
October 3, 2026 at 2:00 AM
Insider selling
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.1M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.1M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
📉 Insider Cluster Sell
4 insiders at CYTOKINETICS INC ($CYTK) sold $2.3M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
4 insiders at CYTOKINETICS INC ($CYTK) sold $2.3M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
September 30, 2026 at 7:20 PM
📉 Insider Cluster Sell
4 insiders at CYTOKINETICS INC ($CYTK) sold $2.3M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
4 insiders at CYTOKINETICS INC ($CYTK) sold $2.3M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
📉 Insider Cluster Sell
5 insiders at CYTOKINETICS INC ($CYTK) sold $7.8M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
5 insiders at CYTOKINETICS INC ($CYTK) sold $7.8M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
September 30, 2026 at 11:40 AM
📉 Insider Cluster Sell
5 insiders at CYTOKINETICS INC ($CYTK) sold $7.8M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
5 insiders at CYTOKINETICS INC ($CYTK) sold $7.8M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
🚨 $CYTK
Blum Robert I (President & CEO) sold 7,500 shares at an average price of $65.4600 per common share. (Date: 2026-09-28)
Blum Robert I (President & CEO) sold 7,500 shares at an average price of $65.4600 per common share. (Date: 2026-09-28)
SEC Filing: CYTK
Click to view the official SEC document.
www.sec.gov
September 28, 2026 at 8:56 PM
🚨 $CYTK
Blum Robert I (President & CEO) sold 7,500 shares at an average price of $65.4600 per common share. (Date: 2026-09-28)
Blum Robert I (President & CEO) sold 7,500 shares at an average price of $65.4600 per common share. (Date: 2026-09-28)
🔴 #CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $68.29
Total: $239K
Filed Sep 21, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 3,500 shares @ $68.29
Total: $239K
Filed Sep 21, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
FormDelta — Insider Trading Alerts
Malik Fady Ibraham just sold $239K in CYTK. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
September 22, 2026 at 10:25 PM
🔴 #CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $68.29
Total: $239K
Filed Sep 21, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 3,500 shares @ $68.29
Total: $239K
Filed Sep 21, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
🚨 $CYTK
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $68.2900 per common share. (Date: 2026-09-22)
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $68.2900 per common share. (Date: 2026-09-22)
SEC Filing: CYTK
Click to view the official SEC document.
www.sec.gov
September 22, 2026 at 10:15 PM
🚨 $CYTK
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $68.2900 per common share. (Date: 2026-09-22)
Malik Fady Ibraham (EVP Research & Development) sold 3,500 shares at an average price of $68.2900 per common share. (Date: 2026-09-22)
Cytokinetics ($CYTK) Stock Hub 2026: MYQORZO, Aficamten and the Hypertrophic Cardiomyopathy Franchise Expansion
https://merlintrader.com/cytokinetics-incorporated-stock-hub/
https://merlintrader.com/cytokinetics-incorporated-stock-hub/
Cytokinetics ($CYTK) Stock Hub: ACACIA, MAPLE, MYQORZO
Cytokinetics ($CYTK) Stock Hub updated Aug. 29, 2026: ACACIA-HCM and MAPLE-HCM analyses, MYQORZO launch, Nov. 14 PDUFA, cash and risks.
merlintrader.com
September 18, 2026 at 10:54 AM
Cytokinetics ($CYTK) Stock Hub 2026: MYQORZO, Aficamten and the Hypertrophic Cardiomyopathy Franchise Expansion
https://merlintrader.com/cytokinetics-incorporated-stock-hub/
https://merlintrader.com/cytokinetics-incorporated-stock-hub/
$XLC-1 $GBTC-1 $DRIP-1 $CRML-1 $SM-1 $XLE-1 $COF-1 $MRK-1 $MMIT-1 $QCOM-1 $VYMI-1 $TOST-1 $NVDX-1 $CYTK-1 $KIM-1 $SMCI-1 $BLFS-1 $UMC-1 $QBTS-1 $AGQ-1 $MU-1 $BCRX-1 $TREX-1 $CAE-1 $CENX-1 $FRO-1 $VKTX-1 $SWKS-1 $JHX-1 $EMN-1 $RGTI-1 $XMTR-1 $RKLB-1 $UPWK-1
September 16, 2026 at 8:09 PM
$XLC-1 $GBTC-1 $DRIP-1 $CRML-1 $SM-1 $XLE-1 $COF-1 $MRK-1 $MMIT-1 $QCOM-1 $VYMI-1 $TOST-1 $NVDX-1 $CYTK-1 $KIM-1 $SMCI-1 $BLFS-1 $UMC-1 $QBTS-1 $AGQ-1 $MU-1 $BCRX-1 $TREX-1 $CAE-1 $CENX-1 $FRO-1 $VKTX-1 $SWKS-1 $JHX-1 $EMN-1 $RGTI-1 $XMTR-1 $RKLB-1 $UPWK-1
📋 Today's Insider Activity — 4 filings
#ARCB — Parks Jason T, VP - Controller(1) (SELL, $116K)
#VIRC — VIRTUE DOUGLAS A, Executive Vice President (BUY, $18K)
#HFWA — Rivera Frederick B, Director (SELL, $37K)
#CYTK — Landry Robert E, Director (SELL, $72K)
📈 Search any ticker → https://www.formdel
#ARCB — Parks Jason T, VP - Controller(1) (SELL, $116K)
#VIRC — VIRTUE DOUGLAS A, Executive Vice President (BUY, $18K)
#HFWA — Rivera Frederick B, Director (SELL, $37K)
#CYTK — Landry Robert E, Director (SELL, $72K)
📈 Search any ticker → https://www.formdel
September 15, 2026 at 10:00 PM
📉 Insider Cluster Sell
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.4M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.4M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
September 15, 2026 at 9:50 PM
📉 Insider Cluster Sell
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.4M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $7.4M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
📄 #CYTK 10-Q — what changed
MD&A now says: "In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted MYQORZO marketing authorization across the United Kingdom for the treatment of symptomatic oHCM in adult patients."
📈 Full redline → https://www.formdelta.com/ticker/CYT
MD&A now says: "In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted MYQORZO marketing authorization across the United Kingdom for the treatment of symptomatic oHCM in adult patients."
📈 Full redline → https://www.formdelta.com/ticker/CYT
FormDelta — Insider Trading Alerts
What CYTOKINETICS INC changed in their own words, quarter over quarter.
www.formdelta.com
September 15, 2026 at 9:30 PM
📄 #CYTK 10-Q — what changed
MD&A now says: "In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted MYQORZO marketing authorization across the United Kingdom for the treatment of symptomatic oHCM in adult patients."
📈 Full redline → https://www.formdelta.com/ticker/CYT
MD&A now says: "In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted MYQORZO marketing authorization across the United Kingdom for the treatment of symptomatic oHCM in adult patients."
📈 Full redline → https://www.formdelta.com/ticker/CYT
🔴 #CYTK — Blum Robert I, President & CEO
SOLD: 97,926 shares @ $69.33
Total: $6.8M
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 97,926 shares @ $69.33
Total: $6.8M
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
FormDelta — Insider Trading Alerts
Blum Robert I just sold $6.8M in CYTK. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
September 15, 2026 at 9:30 PM
🔴 #CYTK — Blum Robert I, President & CEO
SOLD: 97,926 shares @ $69.33
Total: $6.8M
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 97,926 shares @ $69.33
Total: $6.8M
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
🔴 #CYTK — Blum Robert I, President & CEO
SOLD: 7,500 shares @ $73.44
Total: $551K
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 7,500 shares @ $73.44
Total: $551K
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
FormDelta — Insider Trading Alerts
Blum Robert I just sold $551K in CYTK. Track all SEC Form 4 insider trades in real-time.
www.formdelta.com
September 15, 2026 at 9:30 PM
🔴 #CYTK — Blum Robert I, President & CEO
SOLD: 7,500 shares @ $73.44
Total: $551K
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
SOLD: 7,500 shares @ $73.44
Total: $551K
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK
#InsiderTrading #CYTK #StockMarket
📉 Insider Cluster Sell
3 insiders at CYTOKINETICS INC ($CYTK) sold $1.6M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $1.6M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
September 1, 2026 at 8:55 PM
📉 Insider Cluster Sell
3 insiders at CYTOKINETICS INC ($CYTK) sold $1.6M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
3 insiders at CYTOKINETICS INC ($CYTK) sold $1.6M in shares over 7 days.
https://earningsfeed.com/companies/1061983-cytk-cytokinetics-inc?utm_source=bluesky&utm_medium=social&utm_campaign=cluster_sell&utm_content=automated_signal
Expression and Purification of CytK Nanopores https://pubmed.ncbi.nlm.nih.gov/42663949/
August 31, 2026 at 10:44 AM
Expression and Purification of CytK Nanopores https://pubmed.ncbi.nlm.nih.gov/42663949/
$CYTK-1 $LLY-1 $PURR-1 $FLUT-1 $MTN-1 $BEKE-1 $SNXX-1 $NVTS-1 $GDXJ-1 $TMF-1 $NEBX-1 $ABCL-1 $OPFI-1 $INFY-1 $FITB-1 $SGOL-1 $SU-1 $ITB-1 $SILJ-1 $SMCI-1 $JETS-1 $BHF-1 $KMI-1 $NVDX-1 $SHO-1
Daily Wrap - Final Message: Daily Wrap up for 2026-08-28 - 832 events.
#burst_trades #HFT #trading ...
Daily Wrap - Final Message: Daily Wrap up for 2026-08-28 - 832 events.
#burst_trades #HFT #trading ...
August 28, 2026 at 8:14 PM
$CYTK-1 $LLY-1 $PURR-1 $FLUT-1 $MTN-1 $BEKE-1 $SNXX-1 $NVTS-1 $GDXJ-1 $TMF-1 $NEBX-1 $ABCL-1 $OPFI-1 $INFY-1 $FITB-1 $SGOL-1 $SU-1 $ITB-1 $SILJ-1 $SMCI-1 $JETS-1 $BHF-1 $KMI-1 $NVDX-1 $SHO-1
Daily Wrap - Final Message: Daily Wrap up for 2026-08-28 - 832 events.
#burst_trades #HFT #trading ...
Daily Wrap - Final Message: Daily Wrap up for 2026-08-28 - 832 events.
#burst_trades #HFT #trading ...
$CYTK — Other Company Update
Cytokinetics announced the presentation of full results from the ACACIA-HCM trial at the ESC Congress 2026, with simultaneous publication in the New England Journal of Medicine. The press release provides details on the study outcomes, but no specific...
🧵 continued ↓
Cytokinetics announced the presentation of full results from the ACACIA-HCM trial at the ESC Congress 2026, with simultaneous publication in the New England Journal of Medicine. The press release provides details on the study outcomes, but no specific...
🧵 continued ↓
August 28, 2026 at 5:16 PM
$CYTK — Other Company Update
Cytokinetics announced the presentation of full results from the ACACIA-HCM trial at the ESC Congress 2026, with simultaneous publication in the New England Journal of Medicine. The press release provides details on the study outcomes, but no specific...
🧵 continued ↓
Cytokinetics announced the presentation of full results from the ACACIA-HCM trial at the ESC Congress 2026, with simultaneous publication in the New England Journal of Medicine. The press release provides details on the study outcomes, but no specific...
🧵 continued ↓
#$CYTK Aficamten improved symptoms and exercise capacity in nHCM, yet the small effect sizes and higher heart-failure events left little new upside. notreload.xyz/xy/modest-ga...
Modest Gains and Extra Safety Flags Sink CYTK After ESC Data
Detailed ACACIA results delivered statistical success without a bigger commercial or safety story.
notreload.xyz
August 28, 2026 at 4:49 PM
#$CYTK Aficamten improved symptoms and exercise capacity in nHCM, yet the small effect sizes and higher heart-failure events left little new upside. notreload.xyz/xy/modest-ga...
🚨 JUST IN: $CYTK
Cytokinetics' aficamten meets both primary endpoints in Phase 3 ACACIA-HCM nHCM trial
#SEC #stocks #investing #CYTK
🔗 secwatch.observer
Cytokinetics' aficamten meets both primary endpoints in Phase 3 ACACIA-HCM nHCM trial
#SEC #stocks #investing #CYTK
🔗 secwatch.observer
August 28, 2026 at 2:28 PM
🚨 JUST IN: $CYTK
Cytokinetics' aficamten meets both primary endpoints in Phase 3 ACACIA-HCM nHCM trial
#SEC #stocks #investing #CYTK
🔗 secwatch.observer
Cytokinetics' aficamten meets both primary endpoints in Phase 3 ACACIA-HCM nHCM trial
#SEC #stocks #investing #CYTK
🔗 secwatch.observer
🚨 $CYTK
On August 28, 2026, Cytokinetics, Incorporated issued a press release announcing its presentation of the full results of ACACIA-HCM at the European Society of Cardiology (ESC) Congress 2026 and published in the New England Journal of Medicine.
On August 28, 2026, Cytokinetics, Incorporated issued a press release announcing its presentation of the full results of ACACIA-HCM at the European Society of Cardiology (ESC) Congress 2026 and published in the New England Journal of Medicine.
SEC Filing: CYTK
Click to view the official SEC document.
www.sec.gov
August 28, 2026 at 1:23 PM
🚨 $CYTK
On August 28, 2026, Cytokinetics, Incorporated issued a press release announcing its presentation of the full results of ACACIA-HCM at the European Society of Cardiology (ESC) Congress 2026 and published in the New England Journal of Medicine.
On August 28, 2026, Cytokinetics, Incorporated issued a press release announcing its presentation of the full results of ACACIA-HCM at the European Society of Cardiology (ESC) Congress 2026 and published in the New England Journal of Medicine.
Cytokinetics readies FDA filing in non-obstructive HCM #$CYTK firstwordpharma.com/story/7923207
August 28, 2026 at 12:34 PM
Cytokinetics readies FDA filing in non-obstructive HCM #$CYTK firstwordpharma.com/story/7923207
⚠️ $CYTK Cytek Biosciences / Patent Verdict: A jury found infringement on one patent claim, awarding Beckman Coulter $56.1M in damages. While Cytek won on three claims, the potential for a final judgment and appeal creates significant financial and operati...
August 25, 2026 at 1:40 AM
⚠️ $CYTK Cytek Biosciences / Patent Verdict: A jury found infringement on one patent claim, awarding Beckman Coulter $56.1M in damages. While Cytek won on three claims, the potential for a final judgment and appeal creates significant financial and operati...